Text & Content Analysis
This page analyzes how a selected category, entity, or narrative frame appears in recent news coverage within the specified time window. Metrics and breakdowns are derived from the active article corpus.
Explore by Category
Corpus KPIs
Entity
ozempic
Articles
3
From
2026-04-14 11:00:55+00
To
2026-05-03 06:50:01+00
Range
2026-04-03 13:51:24.775997+00 →
2026-05-03 13:51:24.775997+00
Who’s being talked about
Top Entities
| Entity | Label | Mentions | Actions |
|---|---|---|---|
| glp1 | PRODUCT | 3 | 📊 🔍 🧲 |
| ozempic | ORG | 3 | 📊 🔍 🧲 |
| american | NORP | 2 | 📊 🔍 🧲 |
| glp1s | PRODUCT | 2 | 📊 🔍 🧲 |
| wegovy | PERSON | 2 | 📊 🔍 🧲 |
| 5m | MONEY | 1 | 📊 🔍 🧲 |
| about a year ago | DATE | 1 | 📊 🔍 🧲 |
| achondroplasia | PERSON | 1 | 📊 🔍 🧲 |
| alexa | ORG | 1 | 📊 🔍 🧲 |
| alexa canciello | PERSON | 1 | 📊 🔍 🧲 |
| americans | NORP | 1 | 📊 🔍 🧲 |
| aposemaglutide injection | ORG | 1 | 📊 🔍 🧲 |
| apotex | GPE | 1 | 📊 🔍 🧲 |
| april 18 2026 6 | DATE | 1 | 📊 🔍 🧲 |
| arvind venkat | PERSON | 1 | 📊 🔍 🧲 |
| atlantic | LOC | 1 | 📊 🔍 🧲 |
| bethany brookshire | GPE | 1 | 📊 🔍 🧲 |
| biomarin | ORG | 1 | 📊 🔍 🧲 |
| boston | GPE | 1 | 📊 🔍 🧲 |
| bpc157 | ORG | 1 | 📊 🔍 🧲 |
| british columbias | ORG | 1 | 📊 🔍 🧲 |
| buzzy | ORG | 1 | 📊 🔍 🧲 |
| california | GPE | 1 | 📊 🔍 🧲 |
| canada | GPE | 1 | 📊 🔍 🧲 |
| canadian | NORP | 1 | 📊 🔍 🧲 |
Who’s talking
Top Sources (Domains)
| Domain | Articles | % | Actions |
|---|---|---|---|
|
|
1 | 33.33 | 📊 📰 🧲 |
|
|
1 | 33.33 | 📊 📰 🧲 |
|
|
1 | 33.33 | 📊 📰 🧲 |
Articles included
Top entities
Top sources
Top narrative frames
| Pub Date | Category | Domain | Title | Analyze | Author | Sent | Score |
|---|---|---|---|---|---|---|---|
| 2026-05-03 06:50:01+00 | Health |
|
Apotex Gets Health Canada Approval for Generic Semaglutide | Analyze | Jon Napitupulu | 😐 neutral | 0.1055 |
| 2026-04-18 12:00:00+00 | Science |
|
The science behind the peptide craze | Analyze | Bethany Brookshire | 😐 neutral | 0.1512 |
| 2026-04-14 11:00:55+00 | Health |
|
US states drop Medicaid coverage of GLP-1 weight-loss drugs as demand rises | Analyze | Eric Berger | 😐 neutral | 0.1254 |